Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1934 of 3330
Next
>>
>
48326 to 48350 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	2.67	uM	11854.145	0.0665	-0.8074	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	13.3	uM	11854.145	0.0591	-0.8261	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	13.3	uM	11854.145	0.0591	-0.8261	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	66.7	uM	11854.145	0.0561	-0.8339	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	66.7	uM	11854.145	0.0561	-0.8339	1.1581
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.000171	uM	14116.189	0.8798	0.5788	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.000171	uM	14116.189	0.8798	0.5788	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.000853	uM	14116.189	0.6805	-0.0175	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.000853	uM	14116.189	0.6805	-0.0175	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.00427	uM	14116.189	1.0320	1.1196	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.00427	uM	14116.189	1.0320	1.1196	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.0213	uM	14116.189	0.7985	0.3199	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.0213	uM	14116.189	0.7985	0.3199	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.107	uM	14116.189	0.1077	-0.9674	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.107	uM	14116.189	0.1077	-0.9674	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.533	uM	14116.189	0.0137	-0.9993	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.533	uM	14116.189	0.0137	-0.9993	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	2.67	uM	14116.189	0.0031	-1.0000	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	2.67	uM	14116.189	0.0031	-1.0000	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	13.3	uM	14116.189	0.0041	-0.9999	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	13.3	uM	14116.189	0.0041	-0.9999	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	66.7	uM	14116.189	0.4189	-0.5989	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	66.7	uM	14116.189	0.4189	-0.5989	0.5416
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.000171	uM	14230.189	0.9846	0.9343	0.4635
BT-20	TNBC	Basal A	MG-132	Proteasome	Proteasome	0.000171	uM	14230.189	0.9846	0.9343	0.4635

|<
<<
Previous
Page 1934 of 3330
Next
>>
>
48326 to 48350 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)